These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26642708)

  • 1. The Relationship Between Lipoprotein-Associated Phospholipase A(2), Cholesteryl Ester Transfer Protein and Lipid Profile and Risk of Atherosclerosis in Women with Iron Deficiency Anaemia.
    Yang S; Chen XY; Xu XP
    Clin Lab; 2015; 61(10):1463-9. PubMed ID: 26642708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proatherogenic disturbances in lipoprotein profile, associated enzymes and transfer proteins in women with iron deficiency anaemia.
    Meroño T; Sorroche P; Gómez Rosso LA; Casañas L; Boero LE; Arbelbide JA; Brites FD
    Clin Biochem; 2010 Mar; 43(4-5):416-23. PubMed ID: 19850020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Cholesteryl Ester Transfer Protein and Lipoprotein-Associated Phospholipase A2 Activities in Children and Adolescents Presenting High Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio.
    Ferraro F; Martín M; Verona J; Gilligan L; Verona MF; Botta E; Tetzlaff W; Lozano Chiappe E; Boero L; Brites F
    Indian J Pediatr; 2021 Dec; 88(12):1180-1186. PubMed ID: 34097230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute infection with Epstein-Barr virus is associated with atherogenic lipid changes.
    Apostolou F; Gazi IF; Lagos K; Tellis CC; Tselepis AD; Liberopoulos EN; Elisaf M
    Atherosclerosis; 2010 Oct; 212(2):607-13. PubMed ID: 20594556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cholesteryl ester transfer, but not cholesterol esterification, is related to lipoprotein-associated phospholipase A2: possible contribution to an atherogenic lipoprotein profile.
    Dullaart RP; Constantinides A; Perton FG; van Leeuwen JJ; van Pelt JL; de Vries R; van Tol A
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1077-84. PubMed ID: 21252249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein-associated phospholipase A2 (Lp-PLA2) and tumor necrosis factor-alpha (TNF-α) and their relation to premature atherosclerosis in β-thalassemia children.
    Ragab SM; Safan MA; Obeid OM; Sherief AS
    Hematology; 2015 May; 20(4):228-38. PubMed ID: 25056687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipoprotein-associated phospholipase A2 serum levels in patients from different categories of cardiovascular risk].
    Nozadze DN; Sergienko IV; Balakhonova TV; Semenova AE; Vlasik TN; Kukharchuk VV
    Kardiologiia; 2014; 54(3):57-63. PubMed ID: 25102750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.
    Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P
    Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the serum lipoprotein-associated phospholipase A
    Dong L; Tong J; Fan S
    Cardiovasc J Afr; 2023 Nov-Dec 23; 34(5):273-277. PubMed ID: 36637451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress, HDL functionality and effects of intravenous iron administration in women with iron deficiency anemia.
    Meroño T; Dauteuille C; Tetzlaff W; Martín M; Botta E; Lhomme M; Saez MS; Sorroche P; Boero L; Arbelbide J; Chapman MJ; Kontush A; Brites F
    Clin Nutr; 2017 Apr; 36(2):552-558. PubMed ID: 26926576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis.
    Zhang J; Xu DL; Liu XB; Bi SJ; Zhao T; Sui SJ; Ji XP; Lu QH
    Yonsei Med J; 2016 Mar; 57(2):321-7. PubMed ID: 26847282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
    Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
    Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein-associated phospholipase A
    Öngen B; Kalkan Uçar S; Levent E; Azarsız E; Koloğlu T; Çoker M; Sözmen E; Sağın FG
    Ann Clin Biochem; 2017 Sep; 54(5):539-547. PubMed ID: 27614353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Lipoprotein-associated Phospholipase A2 in Serum in Patients With Stage 3-5 Chronic Kidney Disease.
    Wang Y; Li SS; Na SP; Yu CY; Ji Y; Zhao SL; Xie RJ; Bao YS
    Am J Med Sci; 2016 Oct; 352(4):348-353. PubMed ID: 27776715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma.
    Tellis CC; Tselepis AD
    Biochim Biophys Acta; 2009 May; 1791(5):327-38. PubMed ID: 19272461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein-associated phospholipase A2 is a risk factor for diabetic kidney disease.
    Hu Y; Li TT; Zhou W; Lu TT; Li FF; Ding B; Liu BL; Xie XJ; Ma JH
    Diabetes Res Clin Pract; 2019 Apr; 150():194-201. PubMed ID: 30904742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of lipoprotein-associated phospholipase activity A2 with cardiovascular risk factors].
    Acevedo M; Varleta P; Kramer V; Quiroga T; Prieto C; Parada J; Adasme M; Briones L; Navarrete C
    Rev Med Chil; 2013 Nov; 141(11):1382-8. PubMed ID: 24718463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated cholesteryl ester transfer protein (CETP) activity, a major determinant of the atherogenic dyslipidemia, and atherosclerotic cardiovascular disease in South Asians.
    Rashid S; Sniderman A; Melone M; Brown PE; Otvos JD; Mente A; Schulze K; McQueen MJ; Anand SS; Yusuf S
    Eur J Prev Cardiol; 2015 Apr; 22(4):468-77. PubMed ID: 24659026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.